Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients
(2016). Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients. EKB Journal Management System, 54(3), 9-17. doi: 10.21608/ejaps.2016.184572
. "Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients". EKB Journal Management System, 54, 3, 2016, 9-17. doi: 10.21608/ejaps.2016.184572
(2016). 'Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients', EKB Journal Management System, 54(3), pp. 9-17. doi: 10.21608/ejaps.2016.184572
Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients. EKB Journal Management System, 2016; 54(3): 9-17. doi: 10.21608/ejaps.2016.184572

Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients

Egyptian Journal of Pure and Applied Science
Article 2, Volume 54, Issue 3, July 2016, Page 9-17  XML PDF (523.25 K)
Document Type: Original Article
DOI: 10.21608/ejaps.2016.184572
View on SCiNiTO View on SCiNiTO
Statistics
Article View: 81
PDF Download: 99